Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > anyone know

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon May 20, 2021 3:15pm

152 Views

Post# 33241807

RE:RE:RE:RE:RE:RE:anyone know

MoneyMouth wrote:
I don't know why you were so offended by the wording in that last press release. The presentation at the least would have put SVA on these investors radar. So when the mic drops, they'll know and the volume will come flooding in. Why do you seem to think Sernova is going to go forever without anything postive happening? Maybe nothing happens in the next 6 weeks, whatever, but eventually something will and we will be rewarded for our patience. They have derisked themselves over and over again, which means they've derisked your investment over and over again. The reward far outweighs the risk. All it takes is time and patience. Which should be a relatively smooth and easy wait seeing as how we have derisked ourselves. And if you arent sure how we've derisked, maybe look at the fact that they have a cell pouch that actually sustains cells and allows them to deliver whatever therapies to the bloodstream. This is proven. So what? Do you suddenly have a fear that it doesn't work? Why?

Moneymouth,

Its incompetent management ... I said nothing about the science or pouch . If management fails to execute , it does not matter how good the asset is . Toleikis based upon his past performance of 11 years has shown ability to negotiate a pharma deal, doing a decent financing , follow up with proper investor relations / pr . The only thing saving this is Witowski . That's it . Longterm investors have seen this before , the question is are we going to wait another 3 to 5 years to see a doubling of share price ?

The flooding of buying is going to come in after his presentation yesterday . Good one . One of the key large investors who owned a large position and was responsible for financing the immunotherapy deal sold all of his position above $2 . We are talking about more than 10 million shares . There are lots more waiting to get out in the next bounce whole Toleikis fiddles his thumbs , provides no leadership to his team or informs the investors .

Call management and ask about this Moneymouth . See what lip service you get from Toleikis . He will tell you anything you want to hear so you won't sell or at least vote for him at the next AGM.

Like I said, deliver something positive and anything above $2 I will be gone .

Sally